A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy.
- 2024-08-01
- RCT · n = 65
- Medicine 103(32)
- Anju Majeed
- Shaheen Majeed
- Avinash Kadasiddappa Parameswarappa
- Avinash Murali
- Satish Gudimallam
- Chikkalingaiah Siddegowda
- Harshith Chandrashekar
- Lakshmi Mundkur
- PubMed: 39121267
- DOI: 10.1097/md.0000000000039243
- High evidence
- Clinical
A significant reduction in Total Nasal Symptom Score and Total Ocular Symptoms Score was observed in the NSO group compared to the placebo
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 2.5 mg twice a day